Clinical analysis of minimally invasive McKeown esophagectomy for esophageal squamous cell carcinoma in Peking Union Medical College Hospital
10.3760/cma.j.cn112434-20230828-00046
- VernacularTitle:全腔镜McKeown食管鳞癌切除术协和经验
- Author:
Luo ZHAO
1
;
Jia HE
;
Ke ZHAO
;
Zhijun HAN
;
Shanqing LI
;
Li LI
Author Information
1. 中国医学科学院 北京协和医学院 北京协和医院胸外科，北京 100730
- Keywords:
Esophageal squamous cell carcinoma;
Minimally invasive McKeown esophagectomy;
Clinical analysis
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2024;40(2):94-99
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To summarize and analyze the clinical outcome of minimally invasive McKeown esophagectomy for esophageal squamous cell carcinoma.Methods:We retrospectively analyzed the clinical data of patients with esophageal squamous cell carcinoma who received minimally invasive McKeown esophagectomy in Peking Union Medical College Hospital from January 2017 to December 2022. Improved anesthesia methods, monitoring of recurrent laryngeal nerve, minimally invasive gastrostomy, and jejunostomy techniques were introduced in surgical procedure. We evaluated perioperative data and long-term follow-up survival in these patients.Results:A total of 226 esophageal squamous cell carcinoma patients who met the inclusion and exclusion criteria were enrolled, of which 48.2% received neoadjuvant therapy. The mean operation time was( 327 ± 68) min, with a total of 40.5(33, 50) lymph nodes and 27(19, 33) thoracic lymph nodes harvested. The postoperative hospital stay was 9(7, 12) days, and the postoperative complication rate was 36.3%. In terms of learning curve, after 50 patients intraoperative blood loss, postoperative hospital stay, and recurrent laryngeal nerve injury rate were significantly decreased. The number of total lymph nodes, thoracic lymph nodes, and the 106tbl harvested was significantly increased. The median follow-up time was 23.5(14, 47) months, with a loss of follow-up rate of 3.5%. The overall 2-year and 5-year survival rates were 82.6% and 71.8%, respectively.Conclusion:Improved minimally invasive McKeown esophagectomy for esophageal squamous cell carcinoma are safe and acceptable. Learning curve can be shortened, with increased lymph node harvested and decreased postoperative complications, which improving the short-term and long-term outcomes of patients.
